Magic mushroom compound tested for fibromyalgia pain relief

NCT ID NCT06368492

Recruiting now Symptom relief Sponsor: Maastricht University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times

Summary

This study is testing whether low, non-hallucinogenic doses of psilocybin (the active ingredient in magic mushrooms) can reduce pain in people with fibromyalgia, a condition causing widespread pain and fatigue. 35 adults will receive either a placebo or one of two low doses of psilocybin in a double-blind setting. The goal is to see if psilocybin can safely improve pain tolerance and reduce self-reported pain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Leiden University Medical Center
RECRUITING

Leiden, South Holland, 2333, Netherlands

Contact Email: •••••@•••••
Maastricht University
RECRUITING

Maastricht, Limburg, 6226AK, Netherlands

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

FIBROMYALGIA